PROGRAMME

SCIENTIFIC PROGRAMME
TUESDAY, SEPTEMBER 4, 2012
15.00-15.30 Opening Ceremony
15.30-16.00 Keynote lecture
Update on hepatitis C virus
Jean-Michel Pawlotsky (Créteil, France)
Chairperson: Esteban Domingo
16.00-16.30 Keynote lecture
HIV and drug resistance testing
Anna-Maria Geretti (Liverpool, UK)
Chairperson: Miguel Thomson
16.30-17.00 Coffee break and poster viewing
17.00-18.30 Session CMV, inflammation, ageing and cancer
Chairpersons: Elisabeth Puchhammer Stöckl / David Navarro

Emerging role of cytomegalovirus in malignant glioma
Charles S. Cobbs (San Francisco, USA)

A possible role of human cytomegalovirus (HCMV) in cancer, potential new treatment options for HCMV positive tumors?
Cecilia Söderberg-Nauclér (Stockholm, Sweden)

The potential role of cytomegalovirus infection in the development of immune senescence
Paul A. H. Moss (Birmingham, UK)
18.30-19.30 Oral presentations 1: Herpesviruses (O-001 to O-005)
Chairpersons: Elisabeth Puchhammer-Stöckl / David Navarro
19.30-20.45 Welcome reception
WEDNESDAY, SEPTEMBER 5, 2012
08.30-09.00 Keynote lecture
Tenofovir: Status presens anno 2012
Erik De Clercq (Leuven, Belgium)
Chairperson: Paulo Paixao
09.00-09.30 Keynote lecture
Viral quasispecies, pathogenesis and antiviral therapy
Esteban Domingo (Madrid, Spain)
Chairperson: Marion Koopmans
09.30-10.30 Oral presentations 2: Viral hepatitis (O-006 to O-010)
Chairpersons: Hubert G.M. Niesters / Xavier López-Labrador
10.30-11.00 Coffee break and poster viewing
11.00-12.30 Session
Respiratory viral infections

Chairperson: Raúl Ortíz de Lejarazu / Elisabeth Puchhammer-Stöckl

Human metapneumovirus: Epidemiology and  Pathogenesis
Bruno Lina (Lyon, France)

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein: a new paradigm for intervention against the virus
José Antonio Melero (Madrid, Spain)

Rhinovirus infections
Carita Savolainen-Kopra (Helsinki, Finland)
12.30-13.30 Satellite meeting 1. Sponsored by LIFE TECHNOLOGIES
Tools and expertise from Life Technologies: From viral pathogen identification to clinical detection and regulation

Quidel® Molecular Viral Assays and the QuantStudio™Dx CE-IVD qPCR platform

Dr. Tammi Ranalli

EZQC™: A new web based software for assay validation & verification
Dr. Ralf Schoenbrunner

Rapid Viral Pathogen Identification on the Ion PGM Sequencer
Dr. Astrid Ferlinz
13.30-14.30 Lunch and poster viewing
ESCV Council meeting
14.30-15.00
Keynote lecture
Current status of measles and rubella infections in Europe
Claude P. Muller (Luxembourg)
Chairperson: Mick Mulders
15.00-16.00 Satellite meeting 2: Sponsored by QIAGEN
From clinical demand to innovative diagnostic workflow solutions
Chair: Dr. Martin Obermeier (Berlin, Germany)

Viral load monitoring of hepatitis C virus in current clinical treatment decisions
Josep Mallolas (Barcelona, Spain)

Current challenges and impact in HIV diagnostics: the Australian and Asia Pacific experience
Adele Lee-Wriede (Melbourne, Australia)
16.00-16.30 Keynote lecture
Rotavirus in the vaccination era
Miren Iturriza-Gómara (Liverpool, UK)
Chairperson: Javier Buesa
16.30-17.00 Coffee break and poster viewing
17.00-18.00



18.00-19.00
Oral presentations 3: HIV & oncogenic viruses (O-011 to O-015)
Chairpersons: Goura Kudesia / Miguel Thomson

Oral presentations 4: Viral diagnosis and new diagnostic technologies (O-016 to O-020)
Chairpersons: Peter Coyle / Fernando de Ory
19.00-22.00 Visit to the Thyssen-Bornemizsa Museum
and Cocktail at the Westin Palace Hotel
THURSDAY, SEPTEMBER 6, 2012
08.30-09.00 Keynote lecture
New approaches to viral vaccines
Christian Mandl (Vienna, Austria)
Chairperson: Elisabeth Puchhammer-Stöckl
09.00-10.30 Session
New viral diagnostic technologies,
metagenomics and molecular identification of novel viruses
Chairpersons: Peter Coyle / Fernando de Ory

Viral diagnostics: from cell culture to theranostics
Nuria Rabella (Barcelona, Spain)

Impact of next-generation sequencing tools on the detection and characterization of novel emerging agents
Gustavo Palacios (Maryland, USA)

Next generation sequencing technologies in diagnostic virology
Luisa Barzon (Padova, Italy)
10.30-11.00 Coffee break and poster viewing
11.00-12.30 Oral presentations 5: Enteric viruses (O-021 to O-025)
Chairpersons: Marion Koopmans / Javier Buesa

Oral presentations 6: Respiratory viruses (O-026 to O-030)
Chairpersons: Inmaculada Casas / Paulo Paixao
12.30-13.30 Satellite meeting 3: Sponsored by ABBOTT MOLECULAR
"Hepatitis C. New treatment options and diagnostic challenges"
Chair: Rolf Kaiser (Cologne, Germany)

HCV protease inhibitors in clinical practice
Christoph Sarrazin (Frankfurt, Germany)


Comparative analysis of HCV RNA assays in low level viremia
Patrick Braun (Aachen, Germany)
13.30-14.30 Lunch and poster viewing
14.30-15.00 Keynote lecture
New insights into human papillomavirus and polyomavirus pathogenesis
Mariet Feltkamp (Leiden, The Netherlands)
Chairperson: Eithne MacMahon
15.00-15.30 Abbott Award lecture
Human Parechivirus Type 3- The most prevalent picornavirus underlying central nervous system related disease in young children
Heli Harvala (Edinburgh, UK)

15.30-16.00 Keynote lecture
Molecular epidemiology of viruses
Fernando González-Candelas (Valencia, Spain)
Chairperson: David Navarro
16.00-16.30 Coffee break and poster viewing
16.30-17.30 Oral presentations 7: Pathogenesis & immunity (O-031 to O-035)
Chairpersons: Bruno Lina / Luis Enjuanes

Oral presentations 8: Molecular epidemiology of viral infections (O-036 to O-040)
Chairpersons: Fernando González-Candelas / Jan Vinjé
17.30-18.30 Oral presentations 9: Viral Infections in the immunocompromised host (O-041 to O-045)
Chairpersons: Eithne MacMahon / Tomás Pumarola

Oral presentations 10: Viral zoonoses (O-046 to O-050)
Chairpersons: Juan E. Echevarría / Esperanza Gómez-Lucía
18.30-19.00 ESCV General Assembly
FRIDAY, SEPTEMBER 7, 2012
“One world, one health, one virology”
08.30-09.00 Welcome & Opening Ceremony of the ESCV/ ESVV Joint Meeting
09.00-09.30 Keynote lecture: “Where do human RNA viruses come from?”
Mark Woolhouse (Edinburgh, Scotland, UK)
Chairperson: Peter Coyle
09.30-10.30 Session
Influenza viruses in animals and
humans
Chairpersons: Juan Ortín /  Thierry van der Berg

Why do we need more research on animal influenza viruses?
Ilaria Capua (Venice, Italy)

Antigenic properties of the 2009 pandemic H1N1 influenza virus
Adolfo García-Sastre (New York, USA)
10.30-11.30 Coffee break and poster viewing
11.30-12.30 Gardner Lecture ESCV
Bats versus viruses: Enemies or friends

Lin-Fa Wang (Geelong, Victoria, Australia)
12.30-13.30 Session
West Nile virus infections
Chairpersons: Antonio Tenorio /  Stéphan Zientara

Emergence and spread of West Nile virus infections in Central Europe
Norbert Nowotny (Vienna, Austria)

West Nile virus infections in humans
Anna Papa (Thessaloniki, Greece)
13.30-14.30 Lunch and poster viewing
14.30-15.30 Session
Emerging arboviruses: Rift valley fever and Crimean-Congo haemorrhagic fever viruses
Chairpersons: Sándor Belak / Peter Coyle

Emerging arboviruses: Rift valley fever and Crimean-Congo haemorrhagic fever viruses
Robert Swanepoel (Pretoria, South Africa)

The ecology of Crimean-Congo haemorrhagic fever virus: basic findings to evaluate incidence rates
Agustín Estrada-Peña (Zaragoza, Spain)
15.30-16.00 Keynote lecture
Promoting translational researches in clinical
and veterinary virology
Yi-Wei Tang (New York, USA)
Chairperson: Javier Buesa
16.00-16.30 Keynote lecture
How viruses cross the inter-species barrier
Peter Daszak (New York, USA)
Chairperson: José Manuel Sánchez-Vizcaíno
16.30-17.00 Closing ceremony

Note that this programme is still provisional and can be modified